CR overview
CR: EPC1
Accession: Q9H2F5
Protein names: Enhancer of polycomb homolog 1
Function type: Histone Modifier
Histone type: Unkown
Methytor type: Unkown
Aliases: Epl1
PMID: 26350215 32209463
Disease: 0
Go term: 18
Pathway: 1
Hallmark: --
Super Enhancer:

chr10:32663131-32669389 chr10:32635304-32636141 chr10:32605873-32639068 chr10:32634832-32636660 chr10:32605118-32637613 chr10:32595946-32646848 chr10:32620878-32646680 chr10:32634599-32637038 chr10:32634764-32636868 chr10:32634808-32636756 chr10:32634576-32636873 chr10:32606692-32646611 chr10:32620553-32638065 chr10:32634619-32637047 chr10:32634893-32636795 chr10:32583653-32646855 chr10:32595965-32637018 chr10:32606461-32636972 chr10:32621035-32646773 chr10:32596414-32647326 chr10:32621395-32646334 chr10:32633068-32636822 chr10:32606377-32669787 chr10:32620967-32652033 chr10:32634920-32636766 chr10:32635091-32636811 chr10:32583721-32642042 chr10:32633348-32637135 chr10:32633620-32637660 chr10:32602780-32642418 chr10:32620859-32676878 chr10:32583548-32676441 chr10:32555617-32669526 chr10:32558233-32669665 chr10:32532260-32670458 chr10:32621049-32674204 chr10:32620795-32674314 chr10:32634070-32637092 chr10:32542011-32637570 chr10:32595033-32637068 chr10:32596712-32637112 chr10:32634529-32642643 chr10:32663853-32691801 chr10:32656223-32691306

Enhancer:

chr10:32660530-32662560 chr10:32697750-32699470 chr10:33031510-33033850 chr10:32586800-32588350 chr10:32400010-32402330 chr10:32604920-32605630 chr10:32607100-32609080 chr10:32623690-32624990 chr10:32664930-32667410 chr10:31933600-31935250 chr10:32228510-32230850 chr10:32230950-32232930 chr10:32233000-32234450 chr10:32240930-32241760 chr10:32263460-32264660 chr10:32329510-32330120 chr10:32330450-32330920 chr10:32366520-32367450 chr10:32367600-32368410 chr10:32451560-32453200 chr10:32413120-32414270 chr10:32528460-32529300 chr10:32618760-32619490 chr10:32393330-32395590 chr10:32419500-32421530 chr10:32458420-32460890 chr10:32541620-32543520 chr10:32552290-32552730 chr10:32554700-32556640 chr10:33138460-33140730 chr10:32360940-32361940 chr10:32433830-32434380 chr10:32525870-32528030 chr10:32641150-32642580 chr10:32602920-32604230 chr10:32235180-32237500 chr10:32616940-32618460 chr10:32626200-32626590 chr10:32627010-32627830 chr10:32649070-32649600 chr10:32650260-32652150

Promoter:

chr10:32376798-32380798

 ChIP-seq based regulatory details of EPC1
Sample ID CR Biosample type Biosample term name File accession Experiment accession Source
CR_02_0239 EPC1 lymphoblast from chronic myelogenous leukemia lymphoblast from chronic myelogenous leukemia SRR13130490 GSE162118 GEO
CR_02_0240 EPC1 lymphoblast from chronic myelogenous leukemia lymphoblast from chronic myelogenous leukemia SRR13130491 GSE162118 GEO
CR_02_0241 EPC1 lymphoblast from chronic myelogenous leukemia lymphoblast from chronic myelogenous leukemia SRR13130492 GSE162544 GEO
CR_02_0242 EPC1 lymphoblast from chronic myelogenous leukemia lymphoblast from chronic myelogenous leukemia SRR13130496 GSE162544 GEO
CR_02_0243 EPC1 lymphoblast from chronic myelogenous leukemia lymphoblast from chronic myelogenous leukemia SRR13130497 GSE162544 GEO
CR_02_0244 EPC1 lymphoblast from chronic myelogenous leukemia lymphoblast from chronic myelogenous leukemia SRR13130498 GSE162544 GEO
 Downstream target genes of EPC1
 Protein-protein interaction of EPC1
 Annotation of EPC1
 TCGA cancer survival map of EPC1


Calculate the hazards ratio based on Cox PH Model.
Add the 95% CI as dotted line.
Reset Add The plot axis-x order will follow the list.


Calculate the hazards ratio based on Cox PH Model.
We use log2(TPM + 1) for log-scale.
All Add
Reset The plot is based on the datasets of list.